Dexcom Inc DC4

XET: DC4 | ISIN: US2521311074   12/11/2024
65,94 EUR (-1,79%)
(-1,79%)   12/11/2024
Grafiek Dexcom Inc Grafiek Dexcom Inc

Dexcom Inc in het nieuws

11 september 2024 · Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of October 21, 2024 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm · Persbericht

10 september 2024 · Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More · Persbericht

7 september 2024 · DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit · Persbericht

6 september 2024 · Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM · Persbericht

6 september 2024 · SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom · Persbericht

5 september 2024 · DexCom, Inc. (DXCM) Investors: October 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

3 september 2024 · Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM · Persbericht

27 augustus 2024 · Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM · Persbericht

24 augustus 2024 · Class Action Announcement for Dexcom, Inc. (DXCM): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Dexcom, Inc. · Persbericht

23 augustus 2024 · DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM · Persbericht

Profiel Dexcom Inc

dexcom, inc is opgericht in 1999 en levert technologie voor continue glucosemonitoring om patiënten en hun artsen te helpen hun diabetes beter te beheren. sinds onze oprichting hebben we ons gericht op betere resultaten voor patiënten, zorgverleners en artsen door oplossingen te bieden voor mensen met diabetes - terwijl we onze gemeenschap in staat stellen diabetes onder controle te krijgen.

Gezondheidstechnologie
Medische Specialiteiten
Productie
Productie van medische instrumenten

Website: www.dexcom.com

Hoofdzetel: San Diego, California vlag Verenigde Staten

CEO: Kevin Sayer

Werknemers: 5.328

Mijn selecties